Related Experiment Videos
Effects of dobutamine on atrioventricular conduction
American Heart Journal
|October 1, 1975
Summary
Dobutamine, a beta-stimulating catecholamine, significantly improved atrioventricular (A-V) conduction. This study found Dobutamine facilitates A-H intervals without affecting H-V times, suggesting its clinical utility for A-V conduction disturbances.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Atrioventricular (A-V) conduction is critical for cardiac function.
- Understanding the electrophysiological effects of inotropic agents is essential for clinical application.
Purpose of the Study:
- To investigate the effect of Dobutamine on atrioventricular conduction.
- To determine dose-response relationships for A-H and H-V intervals.
Main Methods:
- Bundle of His recordings in six patients under basal and paced conditions.
- Intravenous administration of Dobutamine at 5, 10, and 15 mug/kg/min.
- Analysis of A-H and H-V intervals to assess conduction changes.
Main Results:
- Dobutamine demonstrated dose-dependent facilitation of A-H conduction at 10 and 15 mug/kg/min.
- No significant effect on H-V intervals was observed.
- Heart rate increased only moderately with increasing Dobutamine doses.
Conclusions:
- Dobutamine significantly enhances atrioventricular conduction, specifically the A-H interval.
- The drug does not adversely affect His-ventricular conduction (H-V intervals).
- Dobutamine shows potential as a therapeutic agent for conditions involving A-V conduction disturbances.